|
ATGP3646-250ug
|
NKMax Bio (ATGen)
|
Neprilysin [52-750 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
|
ATGP3646-50ug
|
NKMax Bio (ATGen)
|
Neprilysin [52-750 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
|
HY-12307-1mg
|
MedChemexpress LLC
|
(-)-Indolactam V [CAS 90365-57-4]
|
|
Cancer-Kinase/protease
|
|
|
HY-12307-5mg
|
MedChemexpress LLC
|
(-)-Indolactam V [CAS 90365-57-4]
|
|
Cancer-Kinase/protease
|
|
|
HY-12307-1mL
|
MedChemexpress LLC
|
(-)-Indolactam V [CAS 90365-57-4] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-P3877A-1mg
|
MedChemexpress LLC
|
(Leu31,Pro34)-Peptide YY (human) (TFA)
|
|
|
|
|
HY-P3877A-10mg
|
MedChemexpress LLC
|
(Leu31,Pro34)-Peptide YY (human) (TFA)
|
|
|
|
|
HY-P3877A-5mg
|
MedChemexpress LLC
|
(Leu31,Pro34)-Peptide YY (human) (TFA)
|
|
|
|
|
HY-101202A-10mg
|
MedChemexpress LLC
|
(Rac)-SNC80 [CAS 1217643-87-2]
|
|
|
|
|
HY-101202A-100mg
|
MedChemexpress LLC
|
(Rac)-SNC80 [CAS 1217643-87-2]
|
|
|
|
|
HY-101202A-25mg
|
MedChemexpress LLC
|
(Rac)-SNC80 [CAS 1217643-87-2]
|
|
|
|
|
HY-101202A-5mg
|
MedChemexpress LLC
|
(Rac)-SNC80 [CAS 1217643-87-2]
|
|
|
|
|
HY-101202A-50mg
|
MedChemexpress LLC
|
(Rac)-SNC80 [CAS 1217643-87-2]
|
|
|
|
|
HY-P1159A-10mg
|
MedChemexpress LLC
|
[D-p-Cl-Phe6,Leu17]-VIP (TFA)
|
|
COVID-19-immunoregulation
|
|
|
HY-P1159A-5mg
|
MedChemexpress LLC
|
[D-p-Cl-Phe6,Leu17]-VIP (TFA)
|
|
COVID-19-immunoregulation
|
|
|
HY-W039519-1g
|
MedChemexpress LLC
|
7-Methoxycoumarin-3-carboxylic acid [CAS 20300-59-8]
|
|
Cancer-programmed cell death
|
|
|
HY-W039519-100mg
|
MedChemexpress LLC
|
7-Methoxycoumarin-3-carboxylic acid [CAS 20300-59-8]
|
|
Cancer-programmed cell death
|
|
|
HY-W039519-25mg
|
MedChemexpress LLC
|
7-Methoxycoumarin-3-carboxylic acid [CAS 20300-59-8]
|
|
Cancer-programmed cell death
|
|
|
HY-W039519-50mg
|
MedChemexpress LLC
|
7-Methoxycoumarin-3-carboxylic acid [CAS 20300-59-8]
|
|
Cancer-programmed cell death
|
|
|
HY-P2026-1mg
|
MedChemexpress LLC
|
A 71915 [CAS 132956-87-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P2026-5mg
|
MedChemexpress LLC
|
A 71915 [CAS 132956-87-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12583-1mg
|
MedChemexpress LLC
|
A-366 [CAS 1527503-11-2]
|
|
Cancer-programmed cell death
|
|
|
HY-12583-10mg
|
MedChemexpress LLC
|
A-366 [CAS 1527503-11-2]
|
|
Cancer-programmed cell death
|
|
|
HY-12583-5mg
|
MedChemexpress LLC
|
A-366 [CAS 1527503-11-2]
|
|
Cancer-programmed cell death
|
|
|
HY-12583-50mg
|
MedChemexpress LLC
|
A-366 [CAS 1527503-11-2]
|
|
Cancer-programmed cell death
|
|
